Mixed lineage leukemia: Roles in human malignancies and potential therapy

FEBS Journal

Volumn 277, Issue 8, 2010, Pages 1822-1831

  Marschalek, Rolf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Acute leukemia; AF10; AF4; AF9; Cancer stem cells; ELL; ENL; MLL; MLL fusion proteins; Signaling

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FLAVOPIRIDOL; GLYCOGEN SYNTHASE KINASE 3; HOX PROTEIN; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN AF10; PROTEIN AF4; PROTEIN AF9; PROTEIN DOT1L; PROTEIN ENL; PROTEIN MEIS1; PROTEIN P21; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA7; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; CANCER STEM CELL; CELL FUNCTION; CHROMOSOME REARRANGEMENT; CHRONIC LYMPHATIC LEUKEMIA; GENE IDENTIFICATION; GENE TRANSLOCATION; HUMAN; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL;

ACUTE DISEASE; HUMANS; LEUKEMIA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASMS; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; SIGNAL TRANSDUCTION; TRANSLOCATION, GENETIC;

EID: 77950468810     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07608.x     Document Type: Short Survey

References (55)

1. Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV et al. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351, 533 542.
2. Ayton PM Cleary ML (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17, 2298 2307.
3. Hess JL (2004) Mechanisms of transformation by MLL. Crit Rev Eukaryot Gene Expr 14, 235 254.
4. Eklund EA (2007) The role of HOX genes in malignant myeloid disease. Curr Opin Hematol 14, 85 89.
5. Horton SJ, Grier DG, McGonigle GJ, Thompson A, Morrow M, De Silva I, Moulding DA, Kioussis D, Lappin TR, Brady HJ et al. (2005) Continuous MLL-ENL expression is necessary to establish a 'Hox Code' and maintain immortalization of hematopoietic progenitor cells. Cancer Res 65, 9245 9252.
6. Djabali M, Selleri L, Parry P, Bower M, Young BD Evans GA (1992) A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 2, 113 118.
7. Mozer BA Dawid IB (1989) Cloning and molecular characterization of the trithorax locus of Drosophila melanogaster. Proc Natl Acad Sci USA 86, 3738 3742.
8. Breen TR Harte PJ (1991) Molecular characterization of the trithorax gene, a positive regulator of homeotic gene expression in Drosophila. Mech Dev 35, 113 127.
9. Arai F, Hirao A Suda T (2005) Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc Med 15, 75 79. (Pubitemid 40693391)
10. De Toni F, Racaud-Sultan C, Chicanne G, Mas VM, Cariven C, Mesange F, Salles JP, Demur C, Allouche M, Payrastre B et al. (2006) A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 25, 3113 3122.
11. Hsieh JJD, Cheng EH Korsmeyer SJ (2003) Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell 115, 293 303.
12. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM Canaani E (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10, 1119 1128.
13. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W Cleary ML (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24, 5639 5649.
14. Ruthenburg AJ, Allis CD Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25, 15 30.
15. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E Young RA (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci USA 102, 8603 8608.
16. Lobato MN, Metzler M, Drynan L, Forster A, Pannell R Rabbitts TH (2008) Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias. J Natl Cancer Inst Monogr 39, 58 63.
17. Van Beusechem VW Valerio D (1996) Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 7, 1649 1668.
18. Wong P, Iwasaki M, Somervaille TC, So CWE Cleary ML (2009) Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 21, 2762 2774.
19. Milne TA, Dou Y, Martin ME, Brock HW, Roeder RG Hess JL (2005) MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci USA 102, 14765 14770.
20. Wang GG, Pasillas MP Kamps MP (2006) Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol 26, 3902 3916.
21. Yokoyama A Cleary ML (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14, 36 46.
22. Caslini C, Yang Z, El-Osta M, Milne TA, Slany RK Hess JL (2007) Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res 67, 7275 7283.
23. Caslini C, Serna A, Rossi V, Introna M Biondi A (2004) Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. Leukemia 18, 1064 1071.
24. Gaussmann A, Wenger T, Eberle I, Bursen A, Bracharz S, Herr I, Dingermann T Marschalek R (2007) The combined effects of the two reciprocal t(4;11) fusion proteins, MLL•AF4 and AF4•MLL, confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 26, 3352 3363.
25. Meyer C, Burmeister T, Strehl S, Schneider B, Hubert D, Zach O, Haas O, Klingebiel T, Dingermann T Marschalek R (2007) Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 21, 588 590.
26. Trentin L, Girodan M, Dingermann T, Basso G, te Kronnie G Marschalek R (2009) Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients. Eur J Haematol 83, 406 419.
27. Stam RW, Schneider P, Hagelstein JA, van der Linden MH, Stumpel DJ, de Menezes RX, de Lorenzo P, Valsecchi MG Pieters R (2009) Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood doi: 10.1182/blood-2009-07-233049.
28. Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M, Zwaan CM, Kung AL Armstrong SA (2009) HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 113, 2375 2385.
29. Fuchs U, Rehkamp G, Haas OA, Slany R, König M, Bojesen S, Bohle RM, Damm-Welk C, Ludwig WD, Harbott J et al. (2001) The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia. Proc Natl Acad Sci USA 98, 8756 8761.
30. Strehl S, Borkhardt A, Slany R, Fuchs UE, König M Haas OA (2003) The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene 22, 157 160.
31. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M et al. (2009) New insights into the MLL recombinome of acute leukemias. Leukemia 23, 1490 1499.
32. Peterlin BM Price DH (2006) Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23, 297 305.
33. Zeisig DT, Bittner CB, Zeisig BB, García-Cuéllar MP, Hess JL Slany RK (2005) The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene 24, 5525 5532.
34. Bitoun E, Oliver PL Davies KE (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16, 92 106.
35. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU, Xia X, Jesneck J, Bracken AP, Silverman LB et al. (2008) H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14, 355 368.
36. Bursen A, Schwabe K, Rüster B, Henschler R, Ruthardt M, Dingermann T Marschalek R (2009) The AF4•MLL fusion protein is capable of inducing ALL in mice without requirement of MLL AF4. Blood.
37. Kaur G, Stetler-Stevenson M, Sebers S, Worland P, Sedlacek H, Myers C, Czech J, Naik R Sausville E (1992) Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J Natl Cancer Inst 84, 1736 1740.
38. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM Price DH (2000) Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 275, 28345 28348.
39. Knockaert M, Greengard P Meijer L (2002) Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 23, 417 425.
40. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325 339.
41. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC Cleary ML (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455, 1205 1209.
42. Schreiner S, Birke M, García-Cuéllar MP, Zilles O, Greil J Slany RK (2001) MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. Cancer Res 61, 6480 6486.
43. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J et al. (2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68, 6643 6651.
44. Guo X, Ramirez A, Waddell DS, Li Z, Liu X Wang XF (2008) Axin and GSK3- control Smad3 protein stability and modulate TGF-signaling. Genes Dev 22, 106 120.
45. Sun M, Song L, Li Y, Zhou T Jope RS (2008) Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ 15, 1887 1900.
46. Mueller D, Garcìa-Cuèllar MP, Bach C, Buhl S, Maethner E Slany RK (2009) Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol 7, e1000249, doi: 10.1371/journal.pbio.1000249.
47. Adler HT, Nallaseth FS, Walter G Tkachuk DC (1997) HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A. J Biol Chem 272, 28407 28414.
48. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, Ronchini C, Ronzoni S, Muradore I, Monestiroli S et al. (2009) Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457, 51 56.
49. Seoane J, Le HV, Shen L, Anderson SA Massagué J (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211 223.
50. Barreto G, Schäfer A, Marhold J, Stach D, Swaminathan SK, Handa V, Döderlein G, Maltry N, Wu W, Lyko F et al. (2007) Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445, 671 675.
51. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N Tada T (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25, 2475 2485.
52. Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A Zappia V (2003) p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem 278, 23360 23368.
53. Chan KK, Zhang J, Chia NY, Chan YS, Sim HS, Tan KS, Oh SK, Ng HH Choo AB (2009) KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells 27, 2114 2125.
54. Rowland BD Peeper DS (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6, 11 23.
55. le Viseur C, Hotfilder M, Bomken S, Wilson K, Röttgers S, Schrauder A, Rosemann A, Irving J, Stam RW, Shultz LD et al. (2009) In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 14, 47 58.